Key result
Dexmedetomidine initiation in preterm infants is linked to a ~11 bpm HR drop and improved SpO2.
Why the study?
This study aimed to evaluate cardiorespiratory status in preterm infants receiving dexmedetomidine using high-resolution physiologic data.
Does dexmedetomidine initiation alter cardiorespiratory parameters in critically ill preterm infants?
Observational (n=100)
Does dexmedetomidine initiation alter cardiorespiratory parameters in critically ill preterm infants?
Absolute Event Rate: 141% vs 152%
p-value: p=<0.01
Dexmedetomidine initiation in critically ill preterm infants is associated with a decrease in heart rate and an increase in oxygen saturation and arterial blood pressure over 48 hours.
Does not support changing sedation practices in preterm infants; leaves open need for RCTs on cardiorespiratory effects.
This study aimed to evaluate cardiorespiratory status in preterm infants receiving dexmedetomidine using high-resolution physiologic data. We analyzed preterm infants with continuous heart rate (HR) and oxygen saturation (SpO2) data for 24 hours preceding and 48 hours following dexmedetomidine initiation. Invasive arterial blood pressure (ABP), when available, was analyzed. In 100 infants with a mean gestational age of 28 weeks and high baseline illness severity, mean HR decreased from 152 to 141 beats per minute while mean SpO2 increased from 91 to 93% in the 48 hours after dexmedetomidine initiation (p < 0.01). In 57 infants with continuous ABP monitoring, mean ABP increased from 40 to 42 mm Hg (p = 0.01). Vasoactive-inotropic support increased before and after initiation. We observed cardiorespiratory changes in critically ill preterm infants following dexmedetomidine initiation; mean HR decreased and mean SpO2 increased in the 48 hours after initiation. In a subset, mean ABP increased along with vasoactive-inotropic support.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2024) conducted an observational in Critically ill preterm infants (n=100). Dexmedetomidine vs. 24 hours preceding initiation was evaluated on Mean heart rate (beats per minute) (p=<0.01). Dexmedetomidine initiation in critically ill preterm infants was associated with a decrease in mean heart rate from 152 to 141 bpm and an increase in mean SpO2 from 91% to 93% (p < 0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: